Physician profile
Darrell Vydra
NPI 1689945495
$8,558.45
in general payments reported to CMS, 2019-2025
15 companies · $686 in 2025
The $686 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,202 · 2022: $474 · 2023: $664 · 2024: $1,532 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076 · Travel and Lodging: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.07 |
| Travel and Lodging | $806.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,477.35 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Stryker Corporation | $1,064.53 | 2022-2024 | Augment Injectable, Omnicurve |
| Boston Scientific Corporation | $587.11 | 2023-2025 | General - Pain Management, Infinion 16, Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $300.82 | 2021-2024 | Sprint Pns System |
| Globus Medical, INC. | $266.44 | 2025 | Senza |
| Nevro Corp. | $258.29 | 2022-2024 | Senza |
| Avanos Medical | $142.73 | 2022 | |
| Abbvie INC. | $96.97 | 2022-2025 | Botox |
| Nalu Medical, INC. | $88.16 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $85.94 | 2025 | |
| Pfizer INC. | $63.23 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $48.99 | 2022 | |
| Bioventus LLC | $42.05 | 2023 | Durolane |
| Collegium Pharmaceutical, INC. | $22.14 | 2025 | Xtampza |
| Relievant Medsystems, INC. | $13.70 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Vydra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.